CN113424923A - 一种燕杞西玉代餐粉及其制备方法 - Google Patents
一种燕杞西玉代餐粉及其制备方法 Download PDFInfo
- Publication number
- CN113424923A CN113424923A CN202110797764.8A CN202110797764A CN113424923A CN 113424923 A CN113424923 A CN 113424923A CN 202110797764 A CN202110797764 A CN 202110797764A CN 113424923 A CN113424923 A CN 113424923A
- Authority
- CN
- China
- Prior art keywords
- yanqi
- meal replacement
- replacement powder
- west
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 27
- 235000012054 meals Nutrition 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 19
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 19
- 235000011453 Vigna umbellata Nutrition 0.000 claims abstract description 14
- 240000001417 Vigna umbellata Species 0.000 claims abstract description 14
- 241001633680 Polygonatum odoratum Species 0.000 claims abstract description 13
- 244000068988 Glycine max Species 0.000 claims abstract description 11
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 11
- 240000005373 Panax quinquefolius Species 0.000 claims abstract description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 11
- 235000007319 Avena orientalis Nutrition 0.000 claims abstract description 8
- 241000037831 Polygonatum sibiricum Species 0.000 claims abstract description 7
- 244000185386 Thladiantha grosvenorii Species 0.000 claims abstract description 7
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 claims abstract description 7
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 7
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 6
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 6
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 6
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 6
- 244000075850 Avena orientalis Species 0.000 claims abstract description 4
- 244000241838 Lycium barbarum Species 0.000 claims abstract 2
- 238000004140 cleaning Methods 0.000 claims description 25
- 238000001035 drying Methods 0.000 claims description 16
- 210000000582 semen Anatomy 0.000 claims description 16
- 239000012535 impurity Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 235000002722 Dioscorea batatas Nutrition 0.000 claims description 14
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims description 14
- 240000001811 Dioscorea oppositifolia Species 0.000 claims description 14
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- 150000002333 glycines Chemical class 0.000 claims description 11
- 238000007605 air drying Methods 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 239000003973 paint Substances 0.000 claims description 9
- 210000002421 cell wall Anatomy 0.000 claims description 5
- 238000005520 cutting process Methods 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 238000000643 oven drying Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 239000010977 jade Substances 0.000 claims 10
- 235000004879 dioscorea Nutrition 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 37
- 239000008280 blood Substances 0.000 description 37
- 230000000694 effects Effects 0.000 description 35
- 206010012601 diabetes mellitus Diseases 0.000 description 13
- 210000000952 spleen Anatomy 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 11
- 235000013305 food Nutrition 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 9
- 241000282414 Homo sapiens Species 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 238000005728 strengthening Methods 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052791 calcium Inorganic materials 0.000 description 6
- 235000001465 calcium Nutrition 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 208000024827 Alzheimer disease Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 229910052711 selenium Inorganic materials 0.000 description 5
- 239000011669 selenium Substances 0.000 description 5
- 235000011649 selenium Nutrition 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000209761 Avena Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 244000241872 Lycium chinense Species 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- 206010039966 Senile dementia Diseases 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 235000007686 potassium Nutrition 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 235000005686 eating Nutrition 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 201000005577 familial hyperlipidemia Diseases 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000003914 insulin secretion Effects 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 3
- 235000008696 isoflavones Nutrition 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000015654 memory Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 229910052698 phosphorus Inorganic materials 0.000 description 3
- 235000014786 phosphorus Nutrition 0.000 description 3
- 238000001243 protein synthesis Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 230000002936 tranquilizing effect Effects 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 2
- 208000035240 Disease Resistance Diseases 0.000 description 2
- 206010013954 Dysphoria Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 102000017011 Glycated Hemoglobin A Human genes 0.000 description 2
- 108010014663 Glycated Hemoglobin A Proteins 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- 208000026139 Memory disease Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 150000001746 carotenes Chemical class 0.000 description 2
- 235000005473 carotenes Nutrition 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- -1 phytosterol Chemical class 0.000 description 2
- 235000021395 porridge Nutrition 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BWWAFUZQSLIIIH-UHFFFAOYSA-N 2-phenyl-3H-chromen-3-id-4-one Chemical compound O1C(=[C-]C(=O)C2=CC=CC=C12)C1=CC=CC=C1 BWWAFUZQSLIIIH-UHFFFAOYSA-N 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 208000007848 Alcoholism Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 240000007054 Avena nuda Species 0.000 description 1
- 235000007317 Avena nuda Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 208000009447 Cardiac Edema Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000019025 Hypokalemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 208000020358 Learning disease Diseases 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010030247 Oestrogen deficiency Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 206010000891 acute myocardial infarction Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 201000007930 alcohol dependence Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 201000010989 colorectal carcinoma Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008629 immune suppression Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 230000004410 intraocular pressure Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 201000003723 learning disability Diseases 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000008897 memory decline Effects 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000003821 menstrual periods Effects 0.000 description 1
- 239000000401 methanolic extract Substances 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 230000004793 poor memory Effects 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 208000007645 potassium deficiency Diseases 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 208000004124 rheumatic heart disease Diseases 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种燕杞西玉代餐粉及其制备方法,所述包括由以下重量份数的成分组成:黄豆30‑36%、燕麦10‑22%、红豆2‑14%、西洋参1‑3%、枸杞子2‑6%、罗汉果2‑6%、葛根-10%、山药-14%、玉竹2‑6%、黄精2‑6%和麦芽糊精10‑14%,本发明一种燕杞西玉代餐粉及其制备方法,具有益气补血、增强机体免疫力的作用,产品中含有一种天然降糖成分,能促进、调节胰岛素分泌,让人体的血糖指数处于正常状态,可以有效预防糖尿病的发生,是糖尿病人的食疗佳品。
Description
技术领域
本发明涉及代餐粉,特别涉及一种燕杞西玉代餐粉及其制备方法,属于代餐粉技术领域。
背景技术
养生粥(代餐粉)是根据人们的饮食习惯,中医养生理论,民以食为天,药补不如食补,治末病研发形成的“功能性食品”;是按人体健康状况需求,根据“一种养生粥冲泡粉专利项目”持续研发的系列产品。产品含有中药成分百分之八十左右,临床达到有功效的量,可以代替食品,奶制品,豆制品食用,现有技术中的代餐粉中富含的糖分较多,不适宜于糖尿病患者的食用。
发明内容
本发明的目的在于提供一种燕杞西玉代餐粉及其制备方法,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:一种燕杞西玉代餐粉及其制备方法,所述包括由以下重量份数的成分组成:
作为本发明的一种优选技术方案,所述包括由以下重量份数的成分组成:
作为本发明的一种优选技术方案,所述包括由以下重量份数的成分组成:
作为本发明的一种优选技术方案,所述包括由以下重量份数的成分组成:
作为本发明的一种优选技术方案,所述制备步骤如下:
步骤一:将黄豆、燕麦、红豆、山药分别烘烤熟透备用;
步骤二:将西洋参、枸杞子、罗汉果、玉竹、黄精、葛根烘干去水分备用;
步骤三:以上原料分别粉碎过120罗;除黄豆以外的原料其余加水浸泡,破壁备用;
步骤四:破壁料加入黄豆.麦芽糊精充分搅拌均匀制成颗粒状;烘干去水分,消毒;
步骤五:规格包装:(30克x12袋/盒)分封、消毒、入库。
作为本发明的一种优选技术方案,黄豆、燕麦、红豆、罗汉果和西洋参:捡去杂质,洗净,晾干备用;枸杞子:去杂质、洗净,切开,烘干备用;山药:去须根,洗净,切片,麸炒备用;玉竹黄精:去杂质,洗净,晾干备用;葛根:除去须根,洗净,晒干,切片备用。
与现有技术相比,本发明的有益效果是:本发明一种燕杞西玉代餐粉及其制备方法,具有益气补血、增强机体免疫力的作用,产品中含有一种天然降糖成分,能促进、调节胰岛素分泌,让人体的血糖指数处于正常状态,可以有效预防糖尿病的发生,是糖尿病人的食疗佳品。
具体实施方式
对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。
本发明提供了一种燕杞西玉代餐粉及其制备方法,
黄豆,含各种植物性蛋白、维生素E、维生素B1、维生素B,钙、钾、磷、铁。有清热利湿、益气补血、美容护发护肤、促骨骼发育、降糖降脂,预防心血管疾病,降低糖化血红蛋白、胆固醇、预防阿尔茨海默病,增强机体免疫力,减轻女性更年期综合症状;
燕麦,降低血压、降低胆固醇、防治大肠癌、防治心脏疾病的医疗价值和保健作用。2011年7月至10月,北京大学医学部专家组在内蒙古包头市展开了一场全胚芽裸燕麦米调理干预Ⅱ型糖尿病患者的科研活动,来自全国15个省市的404位糖尿病患者,有96.5%的糖友餐前餐后血糖、糖化血红蛋白、脂肪肝以及胰岛细胞的修复等身体各项指标均得以改善。全世界首次用一种粮食去干预糖尿病,并取得丰硕成果。对于因肝、肾病变,糖尿病,脂肪肝等引起的继发性高脂血症也有同样明显的疗效。长期食用燕麦米,有利于糖尿病和肥胖病的控制。
红豆,热量低,含有蛋白质、钙、钾、铁、硒、维生素B1、维生素E、皂苷、烟酸、膳食纤维、胡萝卜素、植物甾醣、三萜皂苷。其中蛋白质,钾、赖氨酸及B族维生素的含量,亦为豆类中的翘楚。常吃红豆,有补血、促进血液循环,补充经期营养、舒缓经痛。可净化血液、消除疲劳,对心脏病、肾脏病患者都有所助益。有健脾益肾、养心补血、消除水肿的功效。1.健脾益肾红豆有清心养神、健脾益肾功效,加入莲子、百合更有固精益气、止血、强健筋骨等作用。2.清热解毒红豆能解酒、解毒、对心脏病和肾病、水肿患者都有益处。3.利尿消肿,非常适用于心源性和肾源性水肿、肝硬化腹水、脚气病浮肿等。4.调节血糖体内缺钾会引起糖量减退,导致血糖不易被控制,而红小豆是典型的高钾食物,可以帮助糖尿病患者更好地控制血糖。此外,红豆含有较多的膳食纤维,具有良好的润肠通便、降血压、降血脂,调节血糖的作用。5.补血养血红小豆富含铁质,具有补血、促进血液循环、增加体力、增强抵抗力的功效,是贫血患者的理想食物。古代生育过后,会喝红豆汤来补血,效果极佳。
枸杞子,性味甘、平。归肝、肾。枸杞含有胡萝卜素、甜菜碱、维生素A、维生素B1、维生素C和钙、磷、铁等,具有增加白细胞活性、促进肝细胞新生的药理作用,还可降血压、血糖和血脂。提高机体的抗病能力,抵御病邪的侵害,增强机体对各种有害刺激的适应能力。扶正固本、生精补髓、滋阴补肾、益气安神、强身健体、延缓衰老之良药,自古以来就是滋补养人的上品。枸杞子具有改善大脑的功能,增强人的学习记忆能力。有抗疲劳的养生功效。还能起到美白功效。擅长明目,历代医家治疗肝血不足、肾阴亏虚引起的视物昏花和夜盲症,可以减轻体重,治疗肥胖症。
罗汉果,甘、酸、性凉,归肺、大肠经,含大量葡萄糖,果糖、锰、铁、镍、硒、锡、碘、钼等26种无机元素、蛋白质、维生素等。可治急慢性气管炎、咽喉炎、支气管哮喘、百日咳、胃热、便秘、急性扁桃体炎等症。罗汉果中含有的硒达到0.186mg/kg,是粮食的2倍-4倍,而元素硒在冠心病防治、抗衰老、抗癌方面有较好的疗效。能提高血液#渗透压,降低颅内压,脱水作用强于尿素,且持续时间长。防治急性肾功能衰竭病和降低眼球内压,治疗急性青光眼以及代替糖作糖尿病患者的甜味食品或调味剂。含丰富的维生素C,有抗衰老、抗癌及益肤美容作用;有降血脂及减肥作用,可辅助治疗高脂血症,改善肥胖者的形象,是爱美女性的必选水果。
葛根,性味甘、辛,凉;归脾、胃经。葛根解肌退热,生津止渴,升阳止泻;是一种功效颇多的药食两用的食物,
第一,葛根总黄酮以及葛根素,可改善心肌的有氧代谢,扩张血管,改善微循环,从而预防心肌梗死、心肌缺血以及心律失常等多种问题。
第二,葛根还有助于调理更年期综合征,如失眠多梦、头晕目眩、烦躁不安、抑郁等多种症状,这主要是因为它当中含有一种活性比较高的异黄酮,可有效调节内分泌。
第三,葛根中的某些成分可延缓骨骼组织细胞的老化,促进人对钙质的吸收,并防止体内钙质的流失。
第四,这主要是因为它其中的葛根醇提取物,可以直接作用于人类的大脑,促进智力发育,不仅如此,葛根中含有的葛根素和多糖等营养成分,还能滋养大脑,提高脑部功能,所以葛根对防治老年痴呆、记忆力下降、学习记忆障碍有明程的治疗作用,可用于治疗老年性痴呆,智力障碍,记忆力差等症。
第五,葛根对防治癌症也有一定的效果,它当中有大量的总黄酮,这种物质有抑制癌细胞的效果,还可以提高体内NK细胞的活性。葛根中的葛根素是一种天然降糖成分,并且能促进胰岛素分泌,让人体的血糖指数处于正常状态,黄酮类化合物,对清除血液中胆固醇,软化血管,降低血清中甘油三酯含量,从而有效降低高血脂发病率。葛根中富含多达13种异黄酮类物质,葛根异黄酮被誉为天然的植物雌激素,对补充人体内激素不足和调节内分泌有非常好的作用,可以使乳腺细胞活跃、促进乳房乳腺生长发育,使乳房坚挺丰满、青春期自身雌激素不足的女孩可以吃葛根粉使身材丰润,丰满完美、可以使皮肤光滑细嫩。更年期女性吃葛根粉补充体内雌激素分泌的不足,保持身体年轻活力,嫩滑肌肤。
山药,味甘、性平,入肺、脾、肾经;山药含热量、钾、磷、钙、碳水化合物、维生素C、蛋白质、膳食纤维、硒、铁、人所需的18种氨基酸中,山药中含有16种;山药是食中之药,它既可以做成一个保健食品,而且它也有很高的药用价值,中医认为山药不燥不腻。具有健脾补肺、益胃补肾、固肾益精、聪耳明目、助五脏、强筋骨、长志安神、延年益寿的功效。山药含有多种营养素,有强健机体,滋肾益精的作用。肾亏遗精,妇女白带多、小便频数等症。降低血糖:山药含有黏液蛋白,有降低血糖的作用,可用于治疗糖尿病,是糖尿病人的食疗佳品;抗肿瘤的作用,因为山药当中它富含这个多糖,它可以刺激和调节人体的免疫功能,山药多糖对这种化疗导致的,细胞免疫抑制有对抗作用,因此它对恢复细胞免疫有很好的。
玉竹,性微寒;味甘;归肺、胃经。属滋阴养气补血之品,古人称玉竹平补而润,兼有除风热之功,故能驻颜润肤,祛病延年。玉竹补而不腻,不寒不燥,故有"补益五脏,滋养气血,平补而润,兼除风热"之功。《纲目》:主风温自汗灼热,及劳疟寒热,脾胃虚乏,男子小便频数,失精,一切虚损。1.抗衰老:玉竹养阴润燥,生津止渴,能够增强人体抗病能力,推迟衰老。2.滋阴养气:玉竹味甘,多脂,柔润可食,长于养阴,主要作用于脾胃,故久服不伤脾胃。3.润燥润肺:玉竹主治肺阴虚所致的干咳少痰,咽舌燥和温热病后期。4.镇静神经,强心:玉竹果聚糖等,有改善心肌缺氧和肾上腺皮质激素样作用。对心肌的作用与铃兰制剂类似。玉竹对心悸、心绞痛,风湿性心脏病、冠状动脉粥样硬化性心脏病、肺源性心脏病引起的心力衰竭有一定疗效。5、降血脂、血糖:玉竹甲醇提取物对肾上腺素所致高血糖小鼠的血糖值具有明显降低作用。并显示有改善耐糖功能的倾向。玉竹有降低低密度脂蛋白作用,其还有降血糖作用,从而有效预防糖尿病的发生。6、玉竹中有抗氧化作用的成分,可调节人体免疫力,抑制肿瘤的生长。常服玉竹可提高身体素质。补中益气、润泽心肺、延缓衰老、抑制血糖、调节血压。[黄精]性味:甘、微温。归经:如脾,肺、胃经。含生物碱、淀粉、糖等;脾胃虚弱,肺虚咳嗽,消渴(糖尿病)等症。并有降低血压作用;用于病后体弱,或慢性病消耗营养不良。使用注意:黄精宜九蒸九晒使用;消化不良和有湿痰者忌用。
西洋参,1、西洋参中的皂甙可以有效增强中枢神经,达到静心凝神、消除疲劳、增强记忆力等作用,可适用于失眠、烦躁、记忆力衰退及阿尔茨海默病等症状。2、保护心血管系统:常服西洋参可以抗心律失常、抗心肌缺血、抗心肌氧化、气阴两虚、心慌气短疗效明显。有效降低暂时性和持久性血压,有助于高血压、心律失常、冠心病、急性心肌梗死、脑血栓等疾病的恢复。3、可以促进血清蛋白合成、骨髓蛋白合成、器官蛋白合成等,提高机体免疫力,抑制癌细胞生长,有效抵抗癌症。4、可以降低血液凝固性、抑制血小板凝聚、增加血色素;5、治疗糖尿病西洋参可以降低血糖、调节胰岛素分泌、促进糖代谢和脂肪代谢,对治疗糖尿病有一定辅助作用。6、强壮中枢神经,安定身心、增强记忆能力,对老年痴呆症有显着功效;7、抑制癌细胞生长,增加免疫功能长期服用西洋参片可以抑制癌细胞生长,增加免疫功能。
实施例一:所述包括由以下重量份数的成分组成:
进一步地,所述制备步骤如下:
步骤一:将黄豆、燕麦、红豆、山药分别烘烤熟透备用;
步骤二:将西洋参、枸杞子、罗汉果、玉竹、黄精、葛根烘干去水分备用;
步骤三:以上原料分别粉碎过120罗;除黄豆以外的原料其余加水浸泡,破壁备用;
步骤四:破壁料加入黄豆.麦芽糊精充分搅拌均匀制成颗粒状;烘干去水分,消毒;
步骤五:规格包装:(30克x12袋/盒)分封、消毒、入库。
更进一步的,黄豆、燕麦、红豆、罗汉果和西洋参:捡去杂质,洗净,晾干备用;枸杞子:去杂质、洗净,切开,烘干备用;山药:去须根,洗净,切片,麸炒备用;玉竹黄精:去杂质,洗净,晾干备用;葛根:除去须根,洗净,晒干,切片备用。
实施例二:所述包括由以下重量份数的成分组成:
进一步地,所述制备步骤如下:
步骤一:将黄豆、燕麦、红豆、山药分别烘烤熟透备用;
步骤二:将西洋参、枸杞子、罗汉果、玉竹、黄精、葛根烘干去水分备用;
步骤三:以上原料分别粉碎过120罗;除黄豆以外的原料其余加水浸泡,破壁备用;
步骤四:破壁料加入黄豆.麦芽糊精充分搅拌均匀制成颗粒状;烘干去水分,消毒;
步骤五:规格包装:(30克x12袋/盒)分封、消毒、入库。
更进一步的,黄豆、燕麦、红豆、罗汉果和西洋参:捡去杂质,洗净,晾干备用;枸杞子:去杂质、洗净,切开,烘干备用;山药:去须根,洗净,切片,麸炒备用;玉竹黄精:去杂质,洗净,晾干备用;葛根:除去须根,洗净,晒干,切片备用。
实施例三:所述包括由以下重量份数的成分组成:
进一步地,所述制备步骤如下:
步骤一:将黄豆、燕麦、红豆、山药分别烘烤熟透备用;
步骤二:将西洋参、枸杞子、罗汉果、玉竹、黄精、葛根烘干去水分备用;
步骤三:以上原料分别粉碎过120罗;除黄豆以外的原料其余加水浸泡,破壁备用;
步骤四:破壁料加入黄豆.麦芽糊精充分搅拌均匀制成颗粒状;烘干去水分,消毒;
步骤五:规格包装:(30克x12袋/盒)分封、消毒、入库。
更进一步的,黄豆、燕麦、红豆、罗汉果和西洋参:捡去杂质,洗净,晾干备用;枸杞子:去杂质、洗净,切开,烘干备用;山药:去须根,洗净,切片,麸炒备用;玉竹黄精:去杂质,洗净,晾干备用;葛根:除去须根,洗净,晒干,切片备用。
尽管已经示出和描述了本发明的实施例,对于本领域的普通技术人员而言,可以理解在不脱离本发明的原理和精神的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由所附权利要求及其等同物限定。
Claims (6)
5.根据权利要求1所述的一种燕杞西玉代餐粉及其制备方法,其特征在于:所述制备步骤如下:
步骤一:将黄豆、燕麦、红豆、山药分别烘烤熟透备用;
步骤二:将西洋参、枸杞子、罗汉果、玉竹、黄精、葛根烘干去水分备用;
步骤三:以上原料分别粉碎过120罗;除黄豆以外的原料其余加水浸泡,破壁备用;
步骤四:破壁料加入黄豆.麦芽糊精充分搅拌均匀制成颗粒状;烘干去水分,消毒;
步骤五:规格包装:(30克x12袋/盒)分封、消毒、入库。
6.根据权利要求5所述的一种燕杞西玉代餐粉及其制备方法,其特征在于:黄豆、燕麦、红豆、罗汉果和西洋参:捡去杂质,洗净,晾干备用;枸杞子:去杂质、洗净,切开,烘干备用;山药:去须根,洗净,切片,麸炒备用;玉竹黄精:去杂质,洗净,晾干备用;葛根:除去须根,洗净,晒干,切片备用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110797764.8A CN113424923A (zh) | 2021-07-14 | 2021-07-14 | 一种燕杞西玉代餐粉及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110797764.8A CN113424923A (zh) | 2021-07-14 | 2021-07-14 | 一种燕杞西玉代餐粉及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113424923A true CN113424923A (zh) | 2021-09-24 |
Family
ID=77760398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110797764.8A Pending CN113424923A (zh) | 2021-07-14 | 2021-07-14 | 一种燕杞西玉代餐粉及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113424923A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105285952A (zh) * | 2015-10-29 | 2016-02-03 | 华海正元(福建)生物科技有限公司 | 一种营养均衡的代餐粉及其制备方法 |
CN106901335A (zh) * | 2017-01-19 | 2017-06-30 | 湖州师范学院 | 糖尿病人用早晚餐包 |
CN110771880A (zh) * | 2019-11-08 | 2020-02-11 | 国家半干旱农业工程技术研究中心 | 一种降糖藜麦代餐粉及其制备工艺 |
CN111109602A (zh) * | 2020-01-17 | 2020-05-08 | 杨波 | 一种适合糖尿病及高血脂肥胖人群的药膳功能性食品 |
-
2021
- 2021-07-14 CN CN202110797764.8A patent/CN113424923A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105285952A (zh) * | 2015-10-29 | 2016-02-03 | 华海正元(福建)生物科技有限公司 | 一种营养均衡的代餐粉及其制备方法 |
CN106901335A (zh) * | 2017-01-19 | 2017-06-30 | 湖州师范学院 | 糖尿病人用早晚餐包 |
CN110771880A (zh) * | 2019-11-08 | 2020-02-11 | 国家半干旱农业工程技术研究中心 | 一种降糖藜麦代餐粉及其制备工艺 |
CN111109602A (zh) * | 2020-01-17 | 2020-05-08 | 杨波 | 一种适合糖尿病及高血脂肥胖人群的药膳功能性食品 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN100512676C (zh) | 一种具有保健作用的调味料 | |
CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
CN101461483A (zh) | 一种天然五色健美面及制作方法 | |
CN102511867B (zh) | 红枣阿胶枸杞浓浆及其生产工艺 | |
CN107114663A (zh) | 一种果蔬养胃米粉及其制备方法 | |
CN105875781A (zh) | 一种中药保健饼干及其制备方法 | |
CN106174474A (zh) | 一种适用于心脑血管疾病患者食用的特膳食品 | |
CN105341668A (zh) | 一种藜麦养生粥 | |
CN104970421A (zh) | 桂圆阿胶粉复合固体饮料 | |
CN110050999A (zh) | 一种调补气血的代餐食品及其制备方法 | |
CN108991078A (zh) | 一种防控富贵病的桑叶食品及其制备方法 | |
CN111000252A (zh) | 一种减脂且营养均衡的代餐食品及其制备方法 | |
CN103734409A (zh) | 天麻果茶饮料及其生产工艺 | |
CN101455376A (zh) | 一种营养食品及其制备方法 | |
CN105029176A (zh) | 一种山楂复合保健营养米粉及其加工方法 | |
CN102511866A (zh) | 红枣阿胶浓浆及其生产工艺 | |
CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN105639282B (zh) | 菊山弘根养生粉及其制备工艺 | |
CN101991110B (zh) | 野生灵芝系列食品 | |
CN103734767A (zh) | 一种保健食品 | |
CN105056005A (zh) | 一种能降脂减肥的药食同源组合物 | |
CN109123621A (zh) | 一种可调节机体免疫功能抑制血糖升高的保健食品 | |
CN104783174A (zh) | 一种纯天然营养免疫保健固体饮料的配制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |